Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering

Journal of Bioscience and Bioengineering
Keun-Hong ParkKun Na

Abstract

Recent tissue engineering efforts have been focused on the use of natural or synthetic matrices which combine the characteristics of biodegradable properties with those of protein delivery vehicles, allowing for implanted cell actions and enhanced tissue regeneration. The principal objective of this study was to assess the feasibility of ectopic bone formation in a three-dimensional fibrin construct mixed with bone morphogenic protein-2 (BMP-2) loaded in nano-carriers for the osteogenic differentiation of human mesenchymal stem cells (hMSCs). The results of our evaluation showed that the osteogenic differentiation of hMSCs embedded in the fibrin construct was affected significantly by the stimulation of growth factors loaded in nanoparticles. When the osteoinduction activity of hMSCs in fibrin construct was evaluated in an in vitro test followed by RT-PCR, real time-QPCR, Western blotting, histological and immunohistochemical examinations, significant homogeneous bone formation was observed histologically throughout the fibrin construct containing the growth factor (BMP-2) loaded into the nanoparticles. With the above detection techniques, the BMP-2-loaded nanoparticles encapsulated in fibrin constructs evidenced more potent ef...Continue Reading

References

Dec 21, 2005·Journal of Biomaterials Applications·Muzaffer AslanErtunç Dayi
Jul 10, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fa-Ming ChenYan Jin
Oct 6, 2007·Advanced Drug Delivery Reviews·Lauren MacriRichard A F Clark
Mar 20, 2008·The Journal of Bone and Joint Surgery. American Volume·Thomas E PattersonGeorge F Muschler
Feb 26, 2008·Biochemical and Biophysical Research Communications·Jiyuan ZhaoTeruyuki Nagamune
Mar 4, 2008·Biochemical and Biophysical Research Communications·Oju JeonByung-Soo Kim
Mar 5, 2008·Biomaterials·Tsung-Lin Yang, Tai-Horng Young
Jun 12, 2008·Tissue Engineering. Part B, Reviews·Tamer A E AhmedMax Hincke

❮ Previous
Next ❯

Citations

Apr 25, 2012·Cytotechnology·Naotaka KishimotoJunichiro Kotani
Mar 19, 2013·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Morten DahlElse Marie Pinholt
Jun 28, 2011·Tissue Engineering. Part B, Reviews·Zhenglin YuanJeremy J Mao
Oct 19, 2011·Journal of Biomedicine & Biotechnology·Seogjin Seo, Kun Na
Jun 25, 2014·Biomaterials·Francisco M Martin-SaavedraNuria Vilaboa
Jun 18, 2014·Tissue Engineering. Part a·Bo-Ram KimByong-Taek Lee
Sep 12, 2014·International Orthopaedics·Alan NguyenAaron W James
Apr 5, 2014·Journal of Endodontics·John S ColomboRena N D'Souza
Jul 19, 2011·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Arash KhojastehMark Stevens
Nov 8, 2011·Progress in Polymer Science·Sílvia GomesDavid L Kaplan
May 11, 2011·International Journal of Pharmaceutics·Mathilde RogerPhilippe Menei
Mar 21, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Graham G WalmsleyDerrick C Wan
Sep 30, 2015·Advanced Drug Delivery Reviews·Praveena JayaramanDinesh Kumar Srinivasan
Sep 10, 2011·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Sungwoo KimYunzhi Yang
Apr 22, 2015·Biochemical and Biophysical Research Communications·Tong ChenZhi-hui Tang
Mar 1, 2012·Neuroscience Letters·Zin Z Khaing, Christine E Schmidt
Dec 7, 2013·Cytotechnology·Fumito SakamotoNaoyuki Matsumoto
Apr 4, 2017·Biotechnology Progress·Sílvia VieiraJ Miguel Oliveira
Feb 18, 2018·The Journal of Experimental Medicine·Ander AbarrategiDominique Bonnet
Feb 22, 2017·The Open Orthopaedics Journal·M F GriffinP E Butler
Mar 13, 2012·Journal of Tissue Engineering and Regenerative Medicine·Wei-Chuan ChenChao-Ling Yao
Sep 12, 2019·Advanced Science·Ki Hyun HongSoo-Chang Song
Dec 14, 2019·Journal of Materials Science. Materials in Medicine·Menemşe GümüşderelioğluArlin S Kiremitçi
Jan 24, 2020·Journal of Biomedical Materials Research. Part a·Tinke-Marie De WitteNicholas A Peppas
Apr 17, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Piyush Koria
Aug 6, 2020·Macromolecular Bioscience·Sanika SuvarnapathakiGulden Camci-Unal
May 12, 2018·Genes·Julia ScheinpflugFrank Schulze
Jan 17, 2017·Tissue Engineering and Regenerative Medicine·Shivaji KashteSachin Kadam
May 18, 2020·International Journal of Molecular Sciences·Håvard Jostein HaugenJanne Elin Reseland
Mar 21, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Dong Nyoung HeoIl Keun Kwon
Aug 11, 2018·Regenerative Biomaterials·Tinke-Marie De WitteNicholas A Peppas
Jan 1, 2014·Aesthetic Plastic Surgery·Alyssa Reiffel GolasJason A Spector

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.